Once-weekly oral antidiabetic agent and treatment satisfaction: Re: Handelsman Y, Lauring B, Gantz I, etal. A randomized, double-blind, non-inferiority trial evaluating the efficacy and safety of omarigliptin, a once-weekly DPP-4 inhibitor, or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy. Curr Med Res Opin 2017: published online 26 May 2017, doi: 10.1080/03007995.2017

著录项

• 来源
  《Current medical research and opinion》 |2017年第11期|共2页
• 作者

  Takahara Mitsuyoshi; Shiraiwa Toshihiko; Katakami Naoto; Matsuoka Taka-aki; Shimomura Iichiro;

  展开▼
• 作者单位

  Osaka Univ Grad Sch Med Dept Diabet Care Med 2-2 Yamadaoka Suita Osaka 5650871 Japan;

  Shiraiwa Med Clin Kashiwara Japan;

  Osaka Univ Grad Sch Med Dept Metab Med Suita Osaka Japan;

  Osaka Univ Grad Sch Med Dept Metab Med Suita Osaka Japan;

  Osaka Univ Grad Sch Med Dept Metab Med Suita Osaka Japan;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 医药、卫生;
• 关键词

• 入库时间 2022-08-20 00:16:14